skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: With all the volatility we are seeing, I am looking at trading a few stocks so I would like a few suggestions from you. These should be names I wouldn't have a problem holding if the trades don't work out. Both US and Canada. Thank you in advance.

Read Answer Asked by K on March 31, 2023

Q: I'm looking for names in the large cap pharma and biotech sectors. Can you suggest two stocks for each sector that look attractive to you right now for a 5+ year horizon? Thanks.

Read Answer Asked by Stefan on March 10, 2023

Q: Season's greetings - what are your thoughts on MRNA. The skin cancer test results lofted the shares yesterday. It still seems inexpensive, given a sub six PE. I have a small holding and am thinking of investing more. It's well within my portfolio recommendations. Don't understand why it not getting more love with all the viruses running around the world. Thanks

Read Answer Asked by alex on December 16, 2022

Q: These two companies are incredibly innovative and have developed the vaccines that save us all. They are very profitable with Moderna selling at a PE of 5 and BioNtech at a PE of 3.2. Yet they continue to go down. They also have quite a few medicines in their pipelines. I have 65 shares of MRNA in my TFSA. Your thoughts?

Read Answer Asked by Ross on May 09, 2022

Q: Hi can you recommend some healthcare etf funds that trade on the NYSE or NASDAQ, I need exposure in this sector, looking for:
1. Growth based funds with some dividend income
2. Dividend income with lower volatility


Read Answer Asked by Kim on November 19, 2021

Q: Moderna seems to have come back down to earth. Last week the US Gov't started a case because their scientists were not included in the patent, and today they are announcing positive data from a phase 2 study for another mrna product, as well as a C-19 booster authorized for people over 18 years. How does the stock look now? Do they stand to lose profit if they lose the case to the US Gov't? Is it something interesting to buy at this level?

Read Answer Asked by Kim on November 16, 2021

Q: When comparing the two companies would you say thereís a lot of overlap in their businesses? Is one diversified enough in healthcare owning both and if not, which would you prefer? Also, could you recommend a few HC stocks that would compliment either? Thanks!

Read Answer Asked by Michael on October 25, 2021

Q: Donít you think the increase in the MRK stock price is excessive given that the benefits were shown in unvaccinated people which is a shrinking market because more and more people are vaccinated and that this MRK news release shouldnít be a negative for Covid vaccine manufacturers like MRNAÖisnít MRNA a screaming buy now. Isnít the market misunderstanding the news release?

Read Answer Asked by Geoff on October 01, 2021